BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 23266471)

  • 1. Pertussis toxin-sensitive heterotrimeric G(αi/o) proteins mediate WNT/β-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A.
    Halleskog C; Schulte G
    Cell Signal; 2013 Apr; 25(4):822-8. PubMed ID: 23266471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT-3A-induced β-catenin signaling does not require signaling through heterotrimeric G proteins.
    Bowin CF; Inoue A; Schulte G
    J Biol Chem; 2019 Aug; 294(31):11677-11684. PubMed ID: 31235524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins.
    Liu X; Rubin JS; Kimmel AR
    Curr Biol; 2005 Nov; 15(22):1989-97. PubMed ID: 16303557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT signaling in activated microglia is proinflammatory.
    Halleskog C; Mulder J; Dahlström J; Mackie K; Hortobágyi T; Tanila H; Kumar Puli L; Färber K; Harkany T; Schulte G
    Glia; 2011 Jan; 59(1):119-31. PubMed ID: 20967887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
    Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
    Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
    Mi K; Johnson GV
    J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity.
    Kilander MB; Dahlström J; Schulte G
    Cell Signal; 2014 Sep; 26(9):1943-9. PubMed ID: 24873871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation.
    Kim W; Kim SY; Kim T; Kim M; Bae DJ; Choi HI; Kim IS; Jho E
    Oncogene; 2013 Jul; 32(28):3390-6. PubMed ID: 22907437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pertussis toxin on extracellular signal-regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of G(i) proteins at a level distal to receptor coupling.
    Melien O; Sandnes D; Johansen EJ; Christoffersen T
    J Cell Physiol; 2000 Jul; 184(1):27-36. PubMed ID: 10825231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation.
    Halleskog C; Dijksterhuis JP; Kilander MB; Becerril-Ortega J; Villaescusa JC; Lindgren E; Arenas E; Schulte G
    J Neuroinflammation; 2012 May; 9():111. PubMed ID: 22647544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant WNTs differentially activate β-catenin-dependent and -independent signalling in mouse microglia-like cells.
    Kilander MB; Halleskog C; Schulte G
    Acta Physiol (Oxf); 2011 Nov; 203(3):363-72. PubMed ID: 21557822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
    Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
    Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF; Tsai HR; Yang LM; Tsai WJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.